OCB — Rt-Pcr Multigene Expression Test, Sentinel Lymph Node, Cancer Metastasis Detection Class III

FDA Device Classification

FDA product code OCB covers "Rt-Pcr Multigene Expression Test, Sentinel Lymph Node, Cancer Metastasis Detection", a Class III medical device. Submissions are reviewed by the Unknown panel.

Classification Details

Product Code
OCB
Device Class
Class III
Regulation Number
Submission Type
Review Panel
IM
Medical Specialty
Unknown
Implant
No

Definition

A gene expression test for detection of cancer metastasisis an in vitro diagnostic test performed on tissue of interest from patients previously diagnosed with cancer. Results from the test can be used to guide the intra-operative or post-operative decision to remove additional tissue. Post-operative histological evaluation of permanent sections of the tissue specimen, in accordance with usual diagnostic practice and using an appropriate histological sampling scheme, is required.